Summary
The product FASTRIP 150, manufactured by PHARM400, underwent independent testing to verify its composition and potency. The sample, submitted by the Manufacturer Pharmaqo Labs mrp@vitamins.to, was analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis revealed the presence of three active ingredients: Drostanolone Propionate at 62.97 mg/ml, Trenbolone Acetate at 61.18 mg/ml, and Testosterone Propionate at 60.76 mg/ml.
The testing process began on 25 January 2024, with the sample received on 31 January 2024, and analysis completed on 1 February 2024. While the results confirm the presence of the stated compounds, the batch number was not provided, which limits the ability to track the product’s consistency across different batches. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Pharmaqo Labs
- Product Name: FASTRIP 150
- Active Ingredient: Drostanolone Propionate, Trenbolone Acetate, Testosterone Propionate
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #38124
- Testing Ordered: 25 January 2024
- Sample Received: 31 January 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Pharmaqo Labs (Manufacturer)
- Analysis Paid For By: Pharmaqo Labs (Manufacturer)
Testing Results
- Specification: 150 mg/ml (as stated on the label)
- Drostanolone Propionate: 62.97 mg/ml
- Trenbolone Acetate: 61.18 mg/ml
- Testosterone Propionate: 60.76 mg/ml
Verification Details
- Verification URL: https://janoshik.com/tests/38124_735ACXRAXSI1
Evaluation of Manufacturer-Submitted Testing
This analysis highlights the composition of the tested product but warrants careful evaluation due to its submission and funding by the Manufacturer Pharmaqo Labs mrp@vitamins.to. Manufacturer-submitted samples may not fully represent the consistency of products available in the broader market. While Janoshik Analytical is recognized for its transparency and rigorous testing protocols, these findings would benefit from independent validation through third-party testing across multiple batches.
Conclusion
The analysis confirms the presence of Drostanolone Propionate, Trenbolone Acetate, and Testosterone Propionate in the product FASTRIP 150. The measured concentrations are close to the expected values, but the lack of batch information limits the ability to assess product consistency. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding anabolic steroid products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
